跳至主要内容
临床试验/TCTR20210831004
TCTR20210831004尚未招募1 期

Effects of Estrogen therapy on Ghrelin and Leptin level in overweight/obese women with surgical menopause

Ratchadapisek sompoch Endowment fund0 个研究点目标入组 66 人开始时间: 2021年8月31日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
41 Years 至 60 Years(—)
性别
Female

入选标准

  • Postmenopausal women who have undergone bilateral oophorectomy before menopause
  • Within 10 years since menopause
  • BMI in overweight/obese range (Asian criteria)
  • No history of menopausal hormonal therapy use or wash out more than 3 months before recruitment

排除标准

  • Premature ovarian insufficiency (onset of menopause before 40 years)
  • History of cancer, chemotherapy or radiation
  • History of Type 1 or type 2 diabetes, hypertrigleceridemia, immunocompromised host, abnormal thyroid function
  • Contraindication to hormonal therapy (stroke, venous thromboembolism, coronary heart disease, breast cancer, drug hypersensitivity)

研究者

发起方
Ratchadapisek sompoch Endowment fund

相似试验